Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody.
Wang C, Wang L, Yu X, Zhang Y, Meng Y, Wang H, Yang Y, Gao J, Wei H, Zhao J, Lu C, Chen H, Sun Y, Li B.
Wang C, et al. Among authors: wang h, wang l.
Oncotarget. 2017 Jun 27;8(26):42742-42751. doi: 10.18632/oncotarget.17451.
Oncotarget. 2017.
PMID: 28514745
Free PMC article.